|
2024 |
2023 |
||||||||
(dollars in millions) |
Q2 |
Q1 |
Q2 |
|||||||
Adjusted EBITDA |
$ |
31.9 |
|
$ |
28.3 |
|
$ |
43.7 |
|
|
Divided by Total Net Sales |
|
214.2 |
|
|
213.4 |
|
|
230.8 |
|
|
Adjusted EBITDA Margin |
|
14.9 |
% |
|
13.3 |
% |
|
18.9 |
% |
|
*Values in table may not add due to rounding. |
||||||||||
Reconciliation of Net Cash Provided By (Used In) Operating Activities to Free Cash Flow*:
|
2024 |
2023 |
|||||||
(dollars in millions) |
Q2 |
Q1 |
Q2 |
||||||
Net Cash Provided By (Used In) Operating Activities |
$ |
22.9 |
|
$ |
28.1 |
|
|
15.7 |
|
Non-Acquisition Capital Expenditures |
|
(14.1 |
) |
|
(9.4 |
) |
|
(11.5 |
) |
Free Cash Flow |
$ |
8.8 |
|
$ |
18.7 |
|
$ |
4.2 |
|
| *Values in table may not add due to rounding. |
|||||||||
